Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.

MLA

Sparreboom, A., et al. “Disposition of Cremophor EL in Humans Limits the Potential for Modulation of the Multidrug Resistance Phenotype in Vivo.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 4, no. 8, Aug. 1998, pp. 1937–42. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9717822&authtype=sso&custid=ns315887.

APA

Sparreboom, A., Verweij, J., van der Burg, M. E., Loos, W. J., Brouwer, E., Viganò, L., Locatelli, A., de Vos, A. I., Nooter, K., Stoter, G., & Gianni, L. (1998). Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 4(8), 1937–1942.

Chicago

Sparreboom, A, J Verweij, M E van der Burg, W J Loos, E Brouwer, L Viganò, A Locatelli, et al. 1998. “Disposition of Cremophor EL in Humans Limits the Potential for Modulation of the Multidrug Resistance Phenotype in Vivo.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 4 (8): 1937–42. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9717822&authtype=sso&custid=ns315887.